McDonnell Boehnen Hulbert & Berghoff LLP
Full-service intellectual property law firm McDonnell Boehnen Hulbert & Berghoff LLP (MBHB) has named Eric Moran Chair of the Cannabis Practice Group, Amir Shenouda Co-Chair of the Trade Secrets Practice Group, James Suggs Co-Chair of the Biotechnology and Pharmaceuticals Practice Group, and Kevin Noonan Emeritus Chair of the Biotechnology and Pharmaceuticals Practice Group.
“Cannabis and life sciences are dynamic industries where clients face high-stakes IP decisions that impact their ability to commercialize successfully. And trade secrets cuts across all the technologies we support and is an essential piece of a comprehensive IP portfolio,” MBHB Managing Partner Jori Fuller said. “With Eric’s depth across patents, trademarks, and copyrights, Jim’s expertise in chemical and pharmaceutical technologies, and Amir’s background in engineering and complex systems, these practice groups will continue to help clients build IP strategies that support their business success.”
Moran counsels Fortune 500 companies, start-ups, and individuals on patent, trademark, and domain name issues. He also represents clients before district courts, the Federal Circuit, and the Trademark Trial and Appeal Board.
Drawing on experience designing hydraulic and mechanical systems, Dr. Shenouda helps clients in mechanical engineering, electrical engineering, telecommunications, and computer technology with patent prosecution and validity, infringement, and patentability analyses.
Suggs supports clients spanning chemical, polymer, and pharmaceutical technologies with patent procurement, strategic counseling, freedom-to-operate, and due diligence opinions. He also represents clients before district and appellate courts, as well as forums such as the International Trade Commission.
Dr. Noonan has counseled some of the largest biotechnology and pharmaceutical companies in the world on IP issues throughout his more than 30-year career. A molecular biologist and experienced patent lawyer, he helps clients develop effective global patent filing and prosecution strategies. He is also a renowned thought leader in life sciences patent law.
“With decades of experience developing and managing patent portfolios for Fortune 500 companies and major research universities, clients trust Kevin to guide their patent filing and prosecution strategies and help them navigate litigation risks,” Fuller said. “He continues to make a significant impact on the life sciences industry in his work for clients and his insightful public commentary on IP issues.”
Noonan is the first Emeritus Chair at MBHB. Donald L. Zuhn is Co-Chair of the Biotechnology and Pharmaceuticals Practice Group alongside Suggs, who is also Co-Chair of the firm’s Chemical Practice Group. Grantland Drutchas is Co-Chair of MBHB’s Trade Secrets Practice Group alongside Shenouda. In addition to his new role as Chair of the Cannabis Practice Group, Moran leads the firm’s Trademark and Copyright Practice Groups.
About MBHB
McDonnell Boehnen Hulbert & Berghoff LLP (MBHB) provides creative, pragmatic IP business solutions for emerging, midsize and Fortune 100 companies, and academic research institutions. Clients in the U.S. and abroad engage us to secure and enforce their intellectual property rights, from navigating patent office procedures to litigating complex infringement actions. Our attorneys are experienced in the procurement, licensing, enforcement, and defense of patents, trademarks, copyrights, trade secrets, and unfair competition actions in a number of technological disciplines and product categories, including biotechnology and pharmaceuticals, cannabis, chemical, electrical, mechanical and materials, medical device and diagnostics, software and business methods, and telecommunications. Visit mbhb.com for more information on the firm.